Chinese herbal medicine for colorectal cancer: An overview of systematic reviews and evidence map
World Journal of Gastrointestinal Oncology · 15.07.2026 · 18 (7)
DOI: 10.4251/wjgo.120031 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Oncology, online erschienen am 15.07.2026. Verfasst von He-Ping Wang und 6 weiteren Autor:innen. Die Arbeit nennt 88 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Colorectal cancer (CRC) accounts for second place of new cases in China. Chinese herbal medicine (CHM) is widely used as an integrative treatment for CRC. However, evidence on the efficacy of CHM for CRC remains unclear. AIM To evaluate quality of previous systematic reviews (SRs) and summarise evidence on CHM treatment for CRC. METHODS All available online academic databases were systematically searched from the time of their foundation to October 2025, and eligible systematic reviews investigating therapeutic effectiveness and safety of CHM in the treatment of CRC patients were incorporated into this study. Their reporting, methodological and evidence quality were evaluated using the PRISMA, AMSTAR-2, and GRADE. RESULTS Ninety-seven SRs were included in this study. Thirty of the included SRs were assessed as high in reporting quality, 67 as moderate; 12 SRs were assessed as moderate in methodological quality, 27 as low quality, 58 as critically low quality. Seven pieces of evidence assessed as moderate quality by GRADE approach, 40 as low quality, and 46 as very low quality. Moderate-quality evidence showed that orally administered CHM plus XELOX increased the objective response rate (ORR) by 44%. Compound Kushen Injection plus FOLFOX increased ORR by 26% and Karnofsky Performance Status (KPS) improvement rate by 24%. Aidi Injection plus FOLFOX4 chemotherapy increased ORR by 22%, disease control rate by 10% and KPS improvement rate by 30%. CONCLUSION Orally administered CHM and CHM injections combined with chemotherapy have promising effects on tumor response and performance status of patients with advanced CRC.
Zitieren
APA
Wang, H., Qin, X., Xu, B., Lu, T., Gao, R., Lin, M., & Li, J. (2026). Chinese herbal medicine for colorectal cancer: An overview of systematic reviews and evidence map. World Journal of Gastrointestinal Oncology, 18(7). https://doi.org/10.4251/wjgo.120031
Vancouver
Wang H, Qin X, Xu B, Lu T, Gao R, Lin M, et al. Chinese herbal medicine for colorectal cancer: An overview of systematic reviews and evidence map. World Journal of Gastrointestinal Oncology. 2026;18(7). doi:10.4251/wjgo.120031
BibTeX
@article{Wang2026,
author = {Wang, He-Ping and Qin, Xiao-Yan and Xu, Bo-Wen and Lu, Tai-Cheng and Gao, Rui-Ke and Lin, Ming and Li, Jie},
title = {Chinese herbal medicine for colorectal cancer: An overview of systematic reviews and evidence map},
journal = {World Journal of Gastrointestinal Oncology},
year = {2026},
volume = {18},
number = {7},
doi = {10.4251/wjgo.120031}
}
EUVIMED